Both are synthetic research peptides with independent bodies of published literature, most of it in tissue-repair and angiogenesis research
Because the peptide potently and aggressively stimulates angiogenesis via the VEGF/VEGFR2 pathways, there is a theoretical, but highly biologically plausible, risk that BPC-157 could inadvertently supply massive new blood flow to existing, undiagnosed malignant tumors, thereby acting as a catalyst for rapid cancer metastasis
43 With this revision, the diagnostic criteria have changed as well
Yes (8), No (6), Abstained (1) Overall conclusion = YES This vote will be considered by the full committee, FDA, and RFJ Jr
I'm quite thin, which may have something to do with it.
By injecting NAD+ subcutaneously, the body can absorb it quickly, supporting cellular health and overall wellness